Oaktree Acquisition Corp. III Life Sciences Unit
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) - Total Assets
Latest total assets as of September 2025: $201.25 Million USD
Based on the latest financial reports, Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) holds total assets worth $201.25 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oaktree Acquisition Corp. III Life Sciences Unit - Total Assets Trend (2024–2024)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Unit’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Oaktree Acquisition Corp. III Life Sciences Unit - Asset Composition Analysis
Current Asset Composition (December 2024)
Oaktree Acquisition Corp. III Life Sciences Unit's total assets of $201.25 Million consist of 0.8% current assets and 99.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2024–2024)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Unit's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Oaktree Acquisition Corp. III Life Sciences Unit Competitors by Total Assets
Key competitors of Oaktree Acquisition Corp. III Life Sciences Unit based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
Oaktree Acquisition Corp. III Life Sciences Unit - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Oaktree Acquisition Corp. III Life Sciences Unit generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Oaktree Acquisition Corp. III Life Sciences Unit is currently not profitable relative to its asset base.
Oaktree Acquisition Corp. III Life Sciences Unit - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.21 | 2.14 | 2.14 |
| Quick Ratio | 1.21 | 2.14 | 2.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $254.09K | $ 831.00K | $ 831.00K |
Oaktree Acquisition Corp. III Life Sciences Unit - Advanced Valuation Insights
This section examines the relationship between Oaktree Acquisition Corp. III Life Sciences Unit's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 1.00 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $195.25 Million |
| Market Capitalization | $196.19 Million USD |
Valuation Analysis
Near Book Valuation: The market values Oaktree Acquisition Corp. III Life Sciences Unit's assets close to their book value ( 1.00x), suggesting investors view the company's assets at approximately fair value.
Slight Asset Contraction: Oaktree Acquisition Corp. III Life Sciences Unit's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Oaktree Acquisition Corp. III Life Sciences Unit (2024–2024)
The table below shows the annual total assets of Oaktree Acquisition Corp. III Life Sciences Unit from 2024 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $195.25 Million | -- |